Title | Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals. |
Publication Type | Journal Article |
Year of Publication | 2005 |
Authors | Smith, Patrick F., Robert Dicenzo, Alan Forrest, Mark Shelton, Gerald Friedland, Michael Para, Richard Pollard, Margaret Fischl, Robin DiFrancesco, and Gene D. Morse |
Journal | Clinical pharmacokinetics |
Volume | 44 |
Issue | 1 |
Pagination | 99-109 |
Date Published | 2005 |
ISSN | 0312-5963 |
Keywords | Adolescent, Adult, Anti-HIV Agents, Body Weight, Carbamazepine, Continental Population Groups, Delavirdine, Double-Blind Method, Drug Therapy, Combination, Female, HIV Infections, Humans, Male, Metabolic Clearance Rate, Middle Aged, Sex Factors |
Abstract | Delavirdine is a non-nucleoside reverse transcriptase inhibitor used in combination regimens for the treatment of HIV-1 infection. Our objective was to characterise the population pharmacokinetics of delavirdine in HIV-infected patients who participated in the adult AIDS Clinical Trials Group (ACTG) 260 and 261 studies. |
DOI | 10.3109/00952990.2011.568081 |
Alternate Journal | Clin Pharmacokinet |